about
Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant.Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease.S-carboxymethyl-L-cysteine.In-vitro effect of flavonoids from Solidago canadensis extract on glutathione S-transferase.Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine in HepG2 cells.S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.Pesticide toxicity and motor neuron diseasePhenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine.Measurement of phenylalanine monooxygenase (PAH) activities.Fate of the anthelmintic, phenothiazine, in man.Drug peptide conjugates in human urine?An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration.Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine.Mouse recombinant phenylalanine monooxygenase and the S-oxygenation of thioether substrates.Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine by human cytosolic fractions.Human phenylalanine monooxygenase and thioether metabolism.The activity of wild type and mutant phenylalanine hydroxylase with respect to the C-oxidation of phenylalanine and the S-oxidation of S-carboxymethyl-L-cysteine.Induction of cysteine dioxygenase activity by oral administration of cysteine analogues to the rat: implications for drug efficacy and safety.An investigation into possible xenobiotic-endobiotic inter-relationships involving the amino acid analogue drug, S-carboxymethyl-L-cysteine and plasma amino acids in humans.First-in-man dose escalation and pharmacokinetic study of CAP7.1, a novel prodrug of etoposide, in adults with refractory solid tumours.Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosisMetabolic biomarkers of Parkinson's diseaseMonoamine oxidase B and Parkinson's diseaseN-methylation of pyridines in Parkinson's diseaseMonoamine oxidase substrates in Parkinson's diseaseMetabolism of low-dose paracetamol in patients with chronic neurological diseaseXenobiotic metabolism in Alzheimer's diseaseS-methylation in motorneuron disease and Parkinson's diseaseEthanol-induced inhibition of pinocytosis and proteolysis in rat yolk sac in vitroPlatelet monoamine oxidase-B activity in Parkinson's diseaseXenobiotic metabolism in Parkinson's diseaseXenobiotic metabolism in motor neuron diseaseXenobiotic enzyme profiles and Parkinson's diseaseN-methylation of pyridines and Parkinson's diseaseErythrocyte thiolmethyltransferaseHuman metabolism of paracetamol (acetaminophen) at different dose levelsPathways of cysteine metabolism in MND/ALSD-penicillamine metabolism in neurodegenerative diseases: an in vivo/in vitro sulphydryl methylation study
P50
Q36742975-5205F567-0C85-4EC2-A23D-219E6C11F670Q36816757-6E0CD68B-1503-4710-A19D-5AF985C7A2B6Q38002126-220FCD6A-BC58-43CA-9887-457BB8ADDA38Q40322185-05FFCF5A-C145-4E9E-8401-FE54AB459FADQ40387402-E0211375-FFC4-4030-A815-6709E54E99A9Q40842340-2ACFE622-DEB9-4AA0-9A2B-5A84C305B99EQ41370137-1B052721-CE7F-4C07-AEF1-80C6E639BCAEQ42171930-0FFDD9FF-8A13-4376-8EAE-7B8F445B563FQ42715498-356E88C3-DF28-4F07-8847-DB215822098AQ44191388-73B78B53-F5A9-4C37-AA8F-101D3B172197Q44240422-CA33ECAD-8ACD-4A86-B3BB-F1D4A73F647EQ44759772-A218A6CC-275C-49F2-934A-D78910B30667Q44759775-F16822D8-94A2-41F6-A4C7-D024ACDBD9ADQ44999816-51C2E3D8-FA77-4449-BE62-16439166FCADQ45127167-DEDB6F05-E4E6-4C50-89E5-C625D9A6E566Q46050742-DB79CCE1-23E0-4474-A934-359D90439DCFQ46071950-32CB0BB5-3D10-4EC0-8D26-52A10CB337C7Q46173555-2A4F0669-8B8F-44BE-AAC9-A032B1A72568Q46226548-1C9A1162-9A37-456D-B460-8DBDC6734779Q46852000-F87F9CB7-50E8-45ED-8D99-E9FE4980C776Q51373441-D8426326-E210-4BA3-85B3-AB5EC813BE1AQ52838876-D971EFED-E981-4742-AFCB-708A416B7CE6Q64864722-33060DDC-593C-4FEC-AD3E-E894433B8E3CQ67874068-8C79D976-D48A-4112-9081-92AB854F18D8Q68082541-B06D4471-48B6-4CFD-8EB1-2B758B020D04Q68306186-E4BE0DB7-4AD5-46EF-B3B9-91CE6F204BE0Q68644643-1215A1EA-BDC6-4312-B378-72C9D2F62339Q68756463-7CA861B7-1FB8-4E34-AE0F-EB85EAC3AB44Q68821151-B9148041-F385-450E-A21E-CC556639DF80Q69372678-7A4BEFE3-FFFB-479F-B990-1048BD6A198FQ69396942-17BD5C5A-DDD5-4EF0-88A0-20472A977B23Q69403391-0A504FB2-81D1-4454-AC7E-DFF12C634DFCQ69642798-572E34FE-B586-416F-8807-2AF025F43880Q69923802-DAB8F514-3DAB-402B-B10A-1B83370457D7Q70171628-37BDB0C1-BF3A-4E82-868A-5632C2C93E21Q70529378-5CFEC4D0-9570-44FB-8192-91C1B340462EQ71512954-A1914D32-95EB-415F-B206-38A07208B98AQ71752347-5E0B3593-F4B4-4DFC-9B0A-3C4F26EC3D48Q72373902-317BC5D4-19E5-4BE2-8AB6-E7ADA0BACDB2Q72654371-834361BE-BA5B-4B41-BA07-B05B725B1D57
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Glyn B Steventon
@ast
Glyn B Steventon
@en
Glyn B Steventon
@es
Glyn B Steventon
@nl
type
label
Glyn B Steventon
@ast
Glyn B Steventon
@en
Glyn B Steventon
@es
Glyn B Steventon
@nl
prefLabel
Glyn B Steventon
@ast
Glyn B Steventon
@en
Glyn B Steventon
@es
Glyn B Steventon
@nl
P108
P106
P108
P31
P496
0000-0003-1363-7695